REGN | Regeneron Pharmaceuticals
Category: Biotechnology company
Quick infos Headquarters: Tarrytown, New York, United States Trade prices Volume: Market Cap: 64.89B Prev closed: 609.17 Open: 612.1 High: 630.76 Low: 608.76 52 week low: 271.37 52 week high: 646.33 Dividends: No Dividends Next ER: November 4, 2021
About the Company Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988.
Earnings History Date EPS / Forecast Revenue / Forecast August 5, 2021 18.81 / 17.914.24B / 3.97BBeat! May 6, 2021 9.89 / 8.682.53B / 2.5BBeat! February 5, 2021 9.53 / 8.382.42B / 2.42BNovember 5, 2020 8.36 / 6.952.29B / 2.08BBeat! August 5, 2020 7.16 / 5.911.95B / 1.73BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Sep 30, 2021 605.18 607.76 613.58
604.62
545.40K -0.25% Sep 29, 2021 606.70 607.14 612.74
604.97
609.27K 0.28% Sep 28, 2021 605.00 607.22 617.71
603.79
1.22M -2.27% Sep 27, 2021 619.07 636.71 636.71
616.26
777.59K -3.1% Sep 24, 2021 638.90 644.31 644.31
632.45
654.47K -1.18% Sep 23, 2021 646.51 647.00 655.00
644.30
494.57K -0.08% Sep 22, 2021 647.06 646.95 651.01
640.02
561.79K 0.02% Sep 21, 2021 646.95 645.11 656.86
642.81
440.54K 0.95% Sep 20, 2021 640.89 643.84 652.00
636.17
635.62K -1.69% Sep 17, 2021 651.88 649.17 653.00
643.29
762.05K -0.2% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US75886F1075 CUSIP: 75886F107 Founded:1988 Employees:5,400 News
Intellia co-founder and gene editing pioneer Jennifer Doudna outlines future of CRISPR seekingalpha.com Jul 1, 2021 3:53 am Altimmune price targets lowered, Tilray’s next move predicted at BofA - in today's analyst action seekingalpha.com Jun 30, 2021 8:55 pm Lilly and Regeneron monoclonal antibodies among preferred therapies in EU against COVID-19 seekingalpha.com Jun 29, 2021 11:54 pm
Dow Jones Today Lags, Nasdaq Rallies As Merck Exits Covid Vaccine Race; Apple, Microsoft, AMD Rise Ahead Of Earnings investors.com Jan 26, 2021 9:50 am
Regeneron's antibody cocktail effective in preventing COVID-19 infection - study finance.yahoo.com Jan 26, 2021 7:00 am Germany to become first in EU to use COVID-19 antibody therapy seekingalpha.com Jan 26, 2021 6:29 am Regeneron upgraded at BMO; says ‘well-positioned’ for 2021 seekingalpha.com Jan 26, 2021 1:23 am Regeneron says U.S. government to buy 1.25 million doses of its COVID-19 treatment marketwatch.com Jan 25, 2021 6:09 pm
Dow Jones Surges More Than 300 Points, Led By Boeing, Walt Disney, Chevron; What's Wrong With Apple Stock? investors.com Jan 25, 2021 4:42 pm
'We still have a major problem with outpatient testing': Dr. Amesh Adalja finance.yahoo.com Jan 25, 2021 4:06 pm
US STOCKS-Wall St gains steadily while impeachment hearings get underway finance.yahoo.com Jan 25, 2021 2:53 pm Is Regeneron Stock Heading to $590? fool.com Jan 25, 2021 12:58 pm Gene editing stocks buoyed in afternoon trading by Intellia CRISPR success seekingalpha.com Jun 29, 2021 2:25 am Intellia CRISPR gene editing data puts heat on Alnylam; shares down 5% seekingalpha.com Jun 29, 2021 12:42 am Hot Stocks: NTLA leads gene-editing stocks higher; ABUS rises on positive data; PERI raises guidance; QADA going private seekingalpha.com Jun 28, 2021 8:55 pm Intellia in focus after landmark trial data, Unity Biotech wins double upgrade: in today's analyst action seekingalpha.com Jun 28, 2021 8:25 pm Gene editing stocks take off as Intellia development slices through sector seekingalpha.com Jun 28, 2021 5:38 pm EMA to update Regeneron/Sanofi's Dupixent SmPC for adults with atopic dermatitis seekingalpha.com Jun 28, 2021 3:17 pm In a first, Intellia, Regeneron demonstrate CRISPR therapy benefit in the body seekingalpha.com Jun 27, 2021 12:05 am Eli Lilly COVID-19 antibody shipments halted in the U.S. citing prevalence of variants seekingalpha.com Jun 26, 2021 2:39 am This company doesn't provide a dividend.
Key Persons CEO : Leonard S. Schleifer, MD, PhD Talk about Regeneron Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
